December 7, 2015 – Monona, WI –  SHINE Medical Technologies, Inc. (SHINE), a Wisconsin-based company founded in 2010, is dedicated to being the world leader in safe, clean, affordable production of medical isotopes and cancer treatment elements.  SHINE invites the Janesville community to an update on the development of its medical isotope production facility.  Since our last meeting in June, SHINE’s primary regulator, the Nuclear Regulatory Commission, has completed their safety and environmental reviews and recommended the approval of a Construction Permit for the SHINE facility.  Anyone in the Janesville community interested in learning more about SHINE or its planned facility in Janesville is welcome to attend.  There will be an opportunity at the end of the presentation for questions and answers.


Date:   Wednesday, December 9, 2015

Time:   4:30 – 5:30 p.m.

Place:   Holiday Inn Express

3100 Wellington Place

Janesville, WI

This informational meeting is part of SHINE’s commitment to the Janesville community informed and respond to questions on its progress toward building a manufacturing facility in Janesville that will provide molybdenum-99 (moly-99) and other medical isotopes for millions of people each year.

 About Moly-99

Molybdenum-99 (moly-99) is a radioisotope that decays into the diagnostic imaging agent technetium-99m (tech-99m). Tech-99m is used in more than 40 million medical imaging procedures each year, primarily in stress tests to diagnose heart disease and bone scans to stage cancer.  Despite constituting approximately half of world demand for moly-99, the U.S. does not produce any moly-99 domestically and imports 100 percent of its supply from foreign nuclear reactors. The majority of these reactors are beyond their original design life and scheduled to be shut down in the coming years. Previous outages of these aging facilities have caused major isotope shortages, significantly impacting patient care. SHINE was founded to deploy a safe, cost-effective and environmentally friendly technology to produce medical isotopes, including moly‑99.